Cepharanthine, new potential specific medicines compounds for Covid-19, research authorized by state Intellectual Property Office on May 10th 2022

Cepharanthine, according to new patent published on May 10^th 2022, could inhibit Covid-19 virus replication and viral transmission effectively.
The research of Cepharanthine used as anti-COVID-19 agents started on early of 2020. Its effect is comparable to that of Remdesivir.
Cepharanthine (CEP) has long history used as antiinflammatory and antineoplastic active pharmaceutical ingredients (API).

FanPharma offers bulk ingredients of cepharanthine for use in food supplements and healthy products.